why choose us

300×250 Ad Slot

Research Article: Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer

Date Published: 2025-01-07

Abstract:
Background: Oncologic outcomes of conversion surgery for advanced pancreatic cancer (PC) have scarcely been reported. Therefore, this study aimed to investigate the outcomes of conversion surgery with preoperative treatment of FOLFIRINOX or gemcitabine with nab-paclitaxel (GnP) for patients with advanced PC including locally advanced or metastatic PC.

No summary available.

300×250 Ad Slot